Because compounded products vary in concentration, potency, and even chemical form, we can't assume your compounded dose is equivalent to the same number on a brand-name pen
Other risk factors that may increase vulnerability include: Long duration of diabetes (typically more than 10 years) Poor glycaemic control prior to starting GLP-1 therapy (HbA1c significantly above target) Rapid reduction in HbA1c (a drop of more than 2 percentage points [22 mmol/mol] within 36 months) Concurrent hypertension , especially if poorly controlled Diabetic kidney disease (nephropathy), which often correlates with retinopathy severity Previous history of retinal treatment (laser photocoagulation or intravitreal injections) People with type 2 diabetes but no retinopathy appear to have minimal risk of retinopathy progression based on current evidence
Make an appointment today and see its effectiveness for yourself
These medications can help qualified patients, but results depend on nutrition, activity, dose tolerance, side effects, refill access, and realistic long-term planning
Historically, hospitals have filled this gap with newer, complex procedures like CAR-T therapy
Quick Practical Tips You Can Apply Tonight Start with one smaller drink and wait to see how you feel